Journal profile · Rheumatology
Scandinavian Journal of Rheumatology
ISSN 0300-9742 · eISSN 1502-7732 · Informa Healthcare · NORWAY · Bimonthly · Founded 1972
Scandinavian Journal of Rheumatology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.57; hybrid open access; APC charged, amount not published; median 108 days to acceptance (86 articles, last 24 months); community-reported acceptance: fairly easy; 92 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Scandinavian Journal of Rheumatology is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Spondyloarthritis Studies and Treatments, together about 41.9% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Scandinavian Journal of Rheumatology is the official journal of the Scandinavian Society for Rheumatology, a non-profit organization following the statutes of the Scandinavian Society for Rheumatology/Scandinavian Research Foundation. The main objective of the Foundation is to support research and promote information and knowledge about rheumatology and related fields. The annual surplus by running the Journal is awarded to young, talented, researchers within the field of rheumatology. The Scandinavian Journal of Rheumatology is an international scientific journal covering clinical and experimental aspects of rheumatic diseases. The journal provides essential reading for rheumatologists as well as general practitioners, orthopaedic surgeons, radiologists, pharmacologists, pathologists and other health professionals with an interest in patients with rheumatic diseases. The journal publishes original articles as well as reviews, editorials, letters and supplements within the various fields of clinical and experimental rheumatology, including; Epidemiology Aetiology and pathogenesis Treatment and prophylaxis Laboratory aspects including genetics, biochemistry, immunology, immunopathology, microbiology, histopathology, pathophysiology and pharmacology Radiological aspects including X-ray, ultrasonography, CT, MRI and other forms of imaging.
From the journal's Aims & Scope
Research area (LetPub): Rheumatology
Editorial board by country: none in mainland China; most named Sweden 4 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine22.4%
- Systemic Lupus Erythematosus ResearchMedicine11%
- Spondyloarthritis Studies and TreatmentsMedicine8.5%
- Systemic Sclerosis and Related DiseasesMedicine5.6%
- Autoimmune and Inflammatory Disorders ResearchMedicine5.5%
- Monoclonal and Polyclonal Antibodies ResearchMedicine4.6%
- Osteoarthritis Treatment and MechanismsMedicine4.2%
- Vasculitis and related conditionsMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPMCEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Index Medicus
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.57LetPub ·
- Impact factor (publisher) 2025
- 1.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 2Publisher website ·
- CiteScore 2026-06
- 4LetPub ·
- CiteScore (publisher) 2025
- 4Publisher website ·
- SJR 2026-06
- 0.68LetPub ·
- SJR (publisher) 2025
- 0.68Publisher website ·
- SNIP 2026-06
- 0.59LetPub ·
- SNIP (publisher) 2025
- 0.59Publisher website ·
- h-index
- 72LetPub ·
- h-index
- 115OpenAlex ·
- i10-index
- 2,999OpenAlex ·
- 2-year mean citedness
- 1.32OpenAlex ·
- Self-citation rate
- 6.7%LetPub ·
- Share of gold OA articles
- 30.61%LetPub ·
Volume
- Articles per year
- 49LetPub ·
- Downloads per year (publisher)
- 145,000Publisher website ·
Articles by year OpenAlex count · 6,009 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 58 | 29 | 5 |
| 2025 | 92 | 54 | 103 |
| 2024 | 73 | 44 | 186 |
| 2023 | 72 | 27 | 266 |
| 2022 | 93 | 42 | 568 |
| 2021 | 120 | 53 | 1,005 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
108 daysMedian, submission to acceptance · P25–P75 36 days – 154 days
- Acceptance to online
- median 31 days (86 articles)
- Submission to online
- median 150 days
- Sample
- 86 articles with submission and acceptance dates (164 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 17%Publisher website ·
- Submission to first decision
- 9 daysPublisher website ·
- First decision after review
- 58 daysPublisher website ·
- Acceptance to publication
- 38 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted1
- original articleOriginal ArticleLength not stated
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Scandinavian Journal of Rheumatology is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discov…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- NORWAY
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1972
- ISSN
- 0300-9742
- Electronic ISSN
- 1502-7732
- Society / sponsor
- Scandinavian Society for Rheumatology
- Latest issue on the website
- Volume 55, Issue 4 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Scandinavian Journal of Rheumatology
What CAS zone is Scandinavian Journal of Rheumatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Scandinavian Journal of Rheumatology is in Zone 4 of Medicine, and in Zone 4 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Scandinavian Journal of Rheumatology?
The latest impact factor listed by LetPub is 1.57; CiteScore 4, h-index 115.
How long does peer review take at Scandinavian Journal of Rheumatology?
Based on the dates recorded on 86 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 108 days (interquartile range 36–154 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 17%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Scandinavian Journal of Rheumatology based?
Of the 4 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Sweden (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Scandinavian Journal of Rheumatology?
According to LetPub and DOAJ records, Scandinavian Journal of Rheumatology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PMC, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Scandinavian Journal of Rheumatology open access, and what is the APC?
Scandinavian Journal of Rheumatology is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .